Endovia Health Sciences, Inc.
EDVA· NYSE
EDVAEndovia Health Sciences, Inc.
Filed Apr 15, 2026 · 10-K · 105 days after period end · 0001731122-26-000577
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $2.69M | $4.79M |
| Net Income | -$3.21M | -$9.04M | -$5.99M | -$4.79M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Apr 15, 2026 · 105 d after period end
